Industry payments and prescribing patterns of antifibrotic therapy for idiopathic pulmonary fibrosis in the United States

Respiratory Medicine 2026

View at publisher
Authors: Anju Murayama, Elizabeth Stieglitz Tarras, Lina M. Freeman, Genevieve P. Kanter, Deborah Catherine Marshall
DOI: 10.1016/j.rmed.2026.108774
Cited by: 0
References: 12

Fields of Study & Subjects

Pharmaceutical industry and healthcare Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pharmaceutical Economics and Policy

Publication details

Journal / source
Respiratory Medicine
Volume
255
Pages
108774–108774
Publication date
11 March 2026
Language
EN